Andrea Mega

13PUBLICATIONS
62CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Haematological tumoursMetabolic medicineCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 27, 2026
New Treatment Options for MASLD Patients with Type 2 Diabetes.

Andrea Mega, Chiara Turri, Luca Marzi

|Feb 27, 2026
Immunotherapy in Hepatocellular Carcinoma with Portal Vein Tumour Thrombosis: From Poor Prognosis to Curative-Intent Strategies.

Luca Marzi, Rodolfo Sacco, Luisa Siciliani

|Jan 14, 2026
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study.

Elisa Pinto, Filippo Pelizzaro, Vittorio Simeon

|Nov 27, 2025
Improvement of Liver Fibrosis in Patients with MASLD Undergoing Pioglitazone Treatment: An Update.

Cristina Stasi, Andrea Mega

|Jun 13, 2025
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis.

Rodolfo Sacco, Edoardo G Giannini, Raffaella Tortora

|Jan 08, 2025
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma.

Edoardo G Giannini, Andrea Pasta, Maria Corina Plaz Torres

Pageof 3

Frequent Collaborators

7 joint publications

Luca Marzi

7 joint publications

Rodolfo Sacco

6 joint publications

Edoardo Giovanni Giannini

4 joint publications

Gianpaolo Vidili